EP1940455A4 - Dietary supplement formulations for improved delivery of coenzyme q10 and methods of administration - Google Patents

Dietary supplement formulations for improved delivery of coenzyme q10 and methods of administration

Info

Publication number
EP1940455A4
EP1940455A4 EP06758378A EP06758378A EP1940455A4 EP 1940455 A4 EP1940455 A4 EP 1940455A4 EP 06758378 A EP06758378 A EP 06758378A EP 06758378 A EP06758378 A EP 06758378A EP 1940455 A4 EP1940455 A4 EP 1940455A4
Authority
EP
European Patent Office
Prior art keywords
coenzyme
administration
methods
dietary supplement
improved delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06758378A
Other languages
German (de)
French (fr)
Other versions
EP1940455A2 (en
Inventor
Jarrow L Rogovin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jarrow Formulas Inc
Original Assignee
Jarrow Formulas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jarrow Formulas Inc filed Critical Jarrow Formulas Inc
Publication of EP1940455A2 publication Critical patent/EP1940455A2/en
Publication of EP1940455A4 publication Critical patent/EP1940455A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP06758378A 2005-04-14 2006-04-14 Dietary supplement formulations for improved delivery of coenzyme q10 and methods of administration Withdrawn EP1940455A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67104005P 2005-04-14 2005-04-14
PCT/US2006/014416 WO2006110924A2 (en) 2005-04-14 2006-04-14 Dietary supplement formulations for improved delivery of coenzyme q10 and methods of administration

Publications (2)

Publication Number Publication Date
EP1940455A2 EP1940455A2 (en) 2008-07-09
EP1940455A4 true EP1940455A4 (en) 2011-01-26

Family

ID=37087713

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06758378A Withdrawn EP1940455A4 (en) 2005-04-14 2006-04-14 Dietary supplement formulations for improved delivery of coenzyme q10 and methods of administration

Country Status (5)

Country Link
EP (1) EP1940455A4 (en)
CN (1) CN101500599A (en)
AU (2) AU2006235633A1 (en)
CA (1) CA2604952A1 (en)
WO (1) WO2006110924A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI22465B (en) * 2007-03-15 2010-10-29 Valens Int. D.O.O. New combination of water soluble forms of coenzyme q10 and l-carnitin, procedure of preparation and application
CN101480381B (en) * 2009-01-21 2013-01-02 郑微 Coenzyme Q10 pharmaceutical composition
CN102793167B (en) * 2012-08-17 2014-06-11 福州复美达生物科技有限公司 Rosemary antioxidant coenzyme Q10 capsule and preparation method thereof
CN105561329A (en) * 2016-01-22 2016-05-11 辽宁万嘉医药科技有限公司 Cyclodextrin ternary supramolecular inclusion complex compounded with water-soluble coenzyme Q10 and alpha-lipoic acid and preparation method thereof

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986004503A1 (en) * 1985-02-01 1986-08-14 Zambon S.P.A. Pharmaceutical composition containing ubidecarenone
WO1997036577A1 (en) * 1996-04-02 1997-10-09 Pharmos Corporation Solid lipid compositions of lipophilic compounds for enhanced oral bioavailability
US5891469A (en) * 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
US6045826A (en) * 1999-04-02 2000-04-04 National Research Council Of Canada Water-soluble compositions of bioactive lipophilic compounds
US6403116B1 (en) * 2000-11-03 2002-06-11 Triarco Inductries, Inc. Coenzyme Q10 formulation
US20020071868A1 (en) * 1998-04-29 2002-06-13 Univera Pharmaceuticals, Inc. Multicomponent biological vehicle
WO2002051380A1 (en) * 2000-12-22 2002-07-04 Audit Institute For Medical Services And Quality Assurance Gmbh Novel pharmaceutical composition consisting of water-soluble or poorly water-soluble active substances
US20030072798A1 (en) * 2000-01-13 2003-04-17 Alpharx Inc. Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof
US6652891B2 (en) * 2001-12-12 2003-11-25 Herbasway Laboratories, Llc Co-enzyme Q10 dietary supplement

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11165128A (en) * 1997-12-04 1999-06-22 Namiki Precision Jewel Co Ltd Drive device for vibration actuator

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986004503A1 (en) * 1985-02-01 1986-08-14 Zambon S.P.A. Pharmaceutical composition containing ubidecarenone
WO1997036577A1 (en) * 1996-04-02 1997-10-09 Pharmos Corporation Solid lipid compositions of lipophilic compounds for enhanced oral bioavailability
US5891469A (en) * 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
US20020071868A1 (en) * 1998-04-29 2002-06-13 Univera Pharmaceuticals, Inc. Multicomponent biological vehicle
US6045826A (en) * 1999-04-02 2000-04-04 National Research Council Of Canada Water-soluble compositions of bioactive lipophilic compounds
US20030072798A1 (en) * 2000-01-13 2003-04-17 Alpharx Inc. Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof
US6403116B1 (en) * 2000-11-03 2002-06-11 Triarco Inductries, Inc. Coenzyme Q10 formulation
WO2002051380A1 (en) * 2000-12-22 2002-07-04 Audit Institute For Medical Services And Quality Assurance Gmbh Novel pharmaceutical composition consisting of water-soluble or poorly water-soluble active substances
US6652891B2 (en) * 2001-12-12 2003-11-25 Herbasway Laboratories, Llc Co-enzyme Q10 dietary supplement

Also Published As

Publication number Publication date
WO2006110924A2 (en) 2006-10-19
AU2011200677A1 (en) 2011-03-17
AU2006235633A1 (en) 2006-10-19
AU2011200677B2 (en) 2012-08-16
WO2006110924A3 (en) 2009-04-16
CN101500599A (en) 2009-08-05
CA2604952A1 (en) 2006-10-19
EP1940455A2 (en) 2008-07-09

Similar Documents

Publication Publication Date Title
IL272236A (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
IL192967A0 (en) Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
IL193240A0 (en) Dihydrodiazepine derivatives and pharmaceutical compositions containing the same
EP1858555A4 (en) Fucoidan compositions and methods for dietary and nutritional supplements
ZA200809259B (en) Dietary supplements containing probiotics
IL205977A (en) 5-phenylamino-imidazo[1,5-a](pyridine/pyrazine) derivatives and pharmaceutical compositions comprising them
IL189737A0 (en) Pyrazine derivatives, their preparation and pharmaceutical compositions containing them
IL184563A (en) Pharmaceutical foam formulations and their uses
ZA200900345B (en) Preparation of pharmaceutical formulations
ZA200900423B (en) Methods and medicaments for administration of ibuprofen
IL183157A0 (en) High concentration self-microemulsifying coenzyme q10 preparations for nutritional use
IL197877A (en) Uses of aminomethyl-4-imidazole derivatives for the preparation of medicaments and medicaments comprising them
IL195931A0 (en) Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and methods for its production
ZA200801575B (en) Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily
IL197107A0 (en) Pharmaceutical compositions including vitamin d and corticosteriod
IL222432A (en) Formulations of low dose diclofenac and beta-cyclodextrin
IL202111A0 (en) Formulations for the oral administration of therapeutic agents and related methods
EP1757273A4 (en) Preparation for oral administration
PL2308566T3 (en) Use of orally administered probiotic bifidobacteria for human beauty benefits
GB0604647D0 (en) Stabilized food supplements and their derivatives
PL1817017T3 (en) Antioxidant dietary supplement compositions and methods for maintaining healthy skin
IL179215A0 (en) Inhalation powder formulations containing enantiomerically pure beta-agonists
ZA200803574B (en) Dietary fiber formulation and method of administration
EP2196463A4 (en) Preparation of 5,6-dimethylxanthone-4-acetic acid, the derivatives prepared and pharmaceutical formulations thereof
EP1940455A4 (en) Dietary supplement formulations for improved delivery of coenzyme q10 and methods of administration

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071015

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

DAX Request for extension of the european patent (deleted)
R17D Deferred search report published (corrected)

Effective date: 20090416

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/43 20060101AFI20090504BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20101229

RIC1 Information provided on ipc code assigned before grant

Ipc: A23L 1/30 20060101ALI20101222BHEP

Ipc: A61K 38/43 20060101AFI20090504BHEP

17Q First examination report despatched

Effective date: 20121220

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130503